EP2674440 - MULTIVALENT IMMUNOGLOBULIN-BASED BIOACTIVE ASSEMBLIES [Right-click to bookmark this link] | |||
Former [2013/51] | Multivalent immunoglobulin-based bioactive assemblies | ||
[2019/04] | Status | No opposition filed within time limit Status updated on 03.07.2020 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 31.05.2019 | ||
Former | Grant of patent is intended Status updated on 07.01.2019 | ||
Former | Examination is in progress Status updated on 18.01.2017 | Most recent event Tooltip | 09.07.2021 | Lapse of the patent in a contracting state New state(s): HU | published on 11.08.2021 [2021/32] | Applicant(s) | For all designated states IBC Pharmaceuticals, Inc. 300 American Road Morris Plains, NJ 07950 / US | [2013/51] | Inventor(s) | 01 /
Chang, Chien-Hsing c/o IBC Pharmaceuticals, Inc. 300 American Road Morris Plains, NJ 07950 / US | 02 /
Goldenberg, David c/o IBC Pharmaceuticals, Inc. 300 American Road Morris Plains, NJ 07950 / US | 03 /
Rossi, Edmund c/o IBC Pharmaceuticals, Inc. 300 American Road Morris Plains, NJ 07950 / US | [2013/51] | Representative(s) | Bohmann, Armin K. Bohmann Anwaltssozietät Nymphenburger Straße 1 80335 München / DE | [2019/27] |
Former [2013/51] | Bohmann, Armin K. bohmann Anwaltssozietät Nymphenburger Strasse 1 80335 München / DE | Application number, filing date | 13004490.2 | 05.12.2006 | [2013/51] | Priority number, date | US20050751196P | 16.12.2005 Original published format: US 751196 P | US20060782332P | 14.03.2006 Original published format: US 782332 P | WO2006US10762 | 24.03.2006 Original published format: PCT/US2006/010762 | US20060389358 | 24.03.2006 Original published format: US 389358 | US20060391584 | 28.03.2006 Original published format: US 391584 | WO2006US12084 | 29.03.2006 Original published format: PCT/US2006/012084 | WO2006US25499 | 29.06.2006 Original published format: PCT/US2006/025499 | US20060478021 | 29.06.2006 Original published format: US 478021 | US20060864530P | 06.11.2006 Original published format: US 864530 P | [2013/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2674440 | Date: | 18.12.2013 | Language: | EN | [2013/51] | Type: | A3 Search report | No.: | EP2674440 | Date: | 05.03.2014 | Language: | EN | [2014/10] | Type: | B1 Patent specification | No.: | EP2674440 | Date: | 03.07.2019 | Language: | EN | [2019/27] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.02.2014 | Classification | IPC: | C07K16/46, A61K39/395, A61K38/17, A61K48/00, C07K16/00, A61K47/68, C07K16/30, A61K39/00 | [2019/04] | CPC: |
C07K16/468 (EP);
A61K47/6853 (EP);
A61K47/6879 (EP);
C07K16/00 (EP);
C07K16/3007 (EP);
A61K2039/505 (EP);
C07K2317/55 (EP);
C07K2317/624 (EP);
C07K2319/00 (EP);
C07K2319/70 (EP)
(-)
|
Former IPC [2014/10] | C07K16/46, A61K39/395, A61K38/17, A61K48/00, C07K16/00, A61K47/48, C07K16/30, A61K39/00 | ||
Former IPC [2013/51] | C07K16/46, A61K39/395, A61K38/17, A61K48/00, C07K16/00, A61K47/48, C07K16/30 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2013/51] | Title | German: | POLYVALENTE BIOAKTIVE ANORDNUNGEN AUF IMMUNGLOBULINBASIS | [2019/04] | English: | MULTIVALENT IMMUNOGLOBULIN-BASED BIOACTIVE ASSEMBLIES | [2019/04] | French: | ENSEMBLES BIOACTIFS À BASE D'IMMUNOGLOBULINE MULTIVALENT | [2019/04] |
Former [2013/51] | Polyvalente bioaktive Anordnungen auf Immunglobulinbasis | ||
Former [2013/51] | Multivalent immunoglobulin-based bioactive assemblies | ||
Former [2013/51] | Ensembles bioactifs à base d'immunoglobuline multivalent | Examination procedure | 13.09.2013 | Examination requested [2013/51] | 14.10.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 05.01.2015 | Amendment by applicant (claims and/or description) | 10.03.2016 | Despatch of a communication from the examining division (Time limit: M04) | 20.07.2016 | Reply to a communication from the examining division | 10.01.2017 | Despatch of a communication from the examining division (Time limit: M06) | 20.07.2017 | Reply to a communication from the examining division | 14.05.2018 | Cancellation of oral proceeding that was planned for 18.05.2018 | 17.05.2018 | Despatch of a communication from the examining division (Time limit: M01) | 18.05.2018 | Date of oral proceedings (cancelled) | 27.06.2018 | Reply to a communication from the examining division | 08.01.2019 | Communication of intention to grant the patent | 16.05.2019 | Fee for grant paid | 16.05.2019 | Fee for publishing/printing paid | 16.05.2019 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP06848816.2 / EP1959993 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060848816) is 19.09.2011 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/32] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 05.01.2015 | Request for further processing filed | 05.01.2015 | Full payment received (date of receipt of payment) Request granted | 23.01.2015 | Decision despatched | Fees paid | Renewal fee | 13.09.2013 | Renewal fee patent year 03 | 13.09.2013 | Renewal fee patent year 04 | 13.09.2013 | Renewal fee patent year 05 | 13.09.2013 | Renewal fee patent year 06 | 13.09.2013 | Renewal fee patent year 07 | 27.12.2013 | Renewal fee patent year 08 | 22.12.2014 | Renewal fee patent year 09 | 22.12.2015 | Renewal fee patent year 10 | 23.12.2016 | Renewal fee patent year 11 | 21.12.2017 | Renewal fee patent year 12 | 19.12.2018 | Renewal fee patent year 13 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 05.12.2006 | AT | 03.07.2019 | CY | 03.07.2019 | CZ | 03.07.2019 | DK | 03.07.2019 | EE | 03.07.2019 | ES | 03.07.2019 | FI | 03.07.2019 | IT | 03.07.2019 | LT | 03.07.2019 | LV | 03.07.2019 | MC | 03.07.2019 | NL | 03.07.2019 | PL | 03.07.2019 | RO | 03.07.2019 | SE | 03.07.2019 | SI | 03.07.2019 | SK | 03.07.2019 | TR | 03.07.2019 | BG | 03.10.2019 | GR | 04.10.2019 | IS | 03.11.2019 | PT | 04.11.2019 | IE | 05.12.2019 | LU | 05.12.2019 | BE | 31.12.2019 | CH | 31.12.2019 | LI | 31.12.2019 | [2021/32] |
Former [2021/26] | AT | 03.07.2019 | |
CY | 03.07.2019 | ||
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
MC | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SI | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
IE | 05.12.2019 | ||
LU | 05.12.2019 | ||
BE | 31.12.2019 | ||
CH | 31.12.2019 | ||
LI | 31.12.2019 | ||
Former [2020/51] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
MC | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SI | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
IE | 05.12.2019 | ||
LU | 05.12.2019 | ||
BE | 31.12.2019 | ||
CH | 31.12.2019 | ||
LI | 31.12.2019 | ||
Former [2020/46] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
MC | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SI | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
IE | 05.12.2019 | ||
LU | 05.12.2019 | ||
Former [2020/39] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
MC | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SI | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/37] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SI | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/36] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/25] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
SK | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
PT | 04.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/24] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
PT | 04.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/23] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
IT | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
PL | 03.07.2019 | ||
RO | 03.07.2019 | ||
SE | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/22] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
DK | 03.07.2019 | ||
EE | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
SE | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/17] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
SE | 03.07.2019 | ||
TR | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/12] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
SE | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
IS | 03.11.2019 | ||
PT | 04.11.2019 | ||
Former [2020/11] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
ES | 03.07.2019 | ||
FI | 03.07.2019 | ||
LT | 03.07.2019 | ||
LV | 03.07.2019 | ||
NL | 03.07.2019 | ||
SE | 03.07.2019 | ||
BG | 03.10.2019 | ||
GR | 04.10.2019 | ||
PT | 04.11.2019 | ||
Former [2020/10] | AT | 03.07.2019 | |
CZ | 03.07.2019 | ||
FI | 03.07.2019 | ||
LT | 03.07.2019 | ||
NL | 03.07.2019 | ||
SE | 03.07.2019 | ||
BG | 03.10.2019 | ||
PT | 04.11.2019 | ||
Former [2020/09] | CZ | 03.07.2019 | |
FI | 03.07.2019 | ||
LT | 03.07.2019 | ||
NL | 03.07.2019 | ||
Former [2020/08] | LT | 03.07.2019 | |
NL | 03.07.2019 | ||
Former [2020/07] | NL | 03.07.2019 | Documents cited: | Search | [Y]US2003232420 (BRAUN ANDREAS [US], et al) [Y] 1-15 * the whole document *; | [Y]US2003198956 (MAKOWSKI LEE [US], et al) [Y] 1-15 * the whole document *; | [Y] - DEYEV S M ET AL, "Design of multivalent complexes using the barnase-barstar module", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20031201), vol. 21, no. 12, ISSN 1087-0156, pages 1486 - 1492, XP002372739 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/nbt916 | [A] - PLUCKTHUN A ET AL, "New protein engineering approaches to multivalent and bispecific antibody fragments", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (19970601), vol. 3, no. 2, ISSN 1380-2933, pages 83 - 105, XP004126672 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/S1380-2933(97)00067-5 | Examination | - ALTO N M ET AL, "Bioinformatic design of A-kinase anchoring protein-in silico: A potent and selective peptide antagonist of type II protein kinase A anchoring", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATIONAL ACADEMY OF SCIENCES, US, (20030415), vol. 100, no. 8, doi:10.1073/PNAS.0330734100, ISSN 0027-8424, pages 4445 - 4450, XP002375233 DOI: http://dx.doi.org/10.1073/pnas.0330734100 | - NEWLON M G ET AL, "A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, WILEY, DE, (20010101), vol. 20, no. 7, doi:10.1093/EMBOJ/20.7.1651, ISSN 0261-4189, pages 1651 - 1662, XP002978073 DOI: http://dx.doi.org/10.1093/emboj/20.7.1651 | - F S Kinderman, "A Novel and Dynamic Mechanism for AKAP Binding to RII Isoforms of cAMP-dependent Protein Kinase", Mol Cell, England, doi:10., (20060101), pages 397 - 408, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855097/pdf/nihms14355.pdf, (20181116), XP055524633 DOI: http://dx.doi.org/10 | - HAUSKEN Z E ET AL, "Mutational analysis of the A-kinase anchoring protein (AKAP)-binding site on RII: Classification of side chain determinants for anchoring and isoform selective association with akaps", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19961115), vol. 271, no. 46, doi:10.1074/JBC.271.46.29016, ISSN 0021-9258, pages 29016 - 29022, XP002375234 DOI: http://dx.doi.org/10.1074/jbc.271.46.29016 | by applicant | US2005002945 | EP0453082 | US6511663 | US5582996 | US4642334 | US4946778 | US5132405 | US6190886 | US5844094 | US5837242 | WO9844001 | US5989830 | US6239259 | US6809185 | US2003232420 | US4624846 | WO9219273 | US2005079184 | US2004018557 | US2003148409 | US2005014207 | US4699784 | US4046722 | US5565215 | US6379698 | US2003082154 | US5620708 | US5702727 | US6530944 | US6306393 | US5021236 | US4472509 | US4824659 | US4932412 | US5525338 | US5716595 | US5736119 | US5922302 | US6096289 | US6387350 | US6331175 | US6077499 | US4863713 | US5256395 | US6090381 | US6472511 | US6962702 | US6126916 | US6010680 | US5776095 | US5776094 | US5776093 | US5772981 | US5753206 | US5746996 | US5697902 | US5328679 | US5128119 | US5101827 | US4735210 | US4331647 | US4348376 | US4361544 | US4468457 | US4444744 | US4460459 | US4460561 | US4818709 | US4671958 | US4046784 | US5332567 | US5443953 | US5541297 | US5601825 | US5635603 | US5637288 | US5677427 | US5686578 | US5698178 | US5789554 | US6187287 | US6319500 | US5798100 | US6132718 | US6440416 | US5734033 | US6458933 | US5223409 | US5622699 | US6068829 | US5582981 | US5595877 | US5637459 | US5475096 | US5270163 | US2004175756 | US2005048512 | US2005053973 | US2005089932 | US2005221384 | US2005025709 | US5169862 | US5539085 | US5576423 | US5051448 | US5559103 | US5889155 | US4036945 | WO0029584 | WO9111465 | US4683195 | US4683202 | US4800159 | US3817837 | US3850752 | US3939350 | US3996345 | US4277437 | US4275149 | US4366241 | US6054495 | US6127120 | US6149868 | - NITTA ET AL., LANCET, (1990), vol. 355, pages 368 - 371 | - KUFER ET AL., TRENDS IN BIOTECHNOL., (2004), vol. 22, pages 238 - 244 | - MACK ET AL., PROC NATL ACAD SCI U.S.A., (1995), vol. 92, pages 7021 - 7025 | - MACK ET AL., J IMMONOL., (1997), vol. 158, pages 3965 - 3970 | - LOFFLER, BLOOD, (2000), vol. 95, pages 2098 - 2103 | - DREIER ET AL., INT J CANCER., (2002), vol. 100, pages 690 - 697 | - DREIER ET AL., J IMMUNOL., (2003), vol. 170, pages 4397 - 4404 | - SCHLERETH ET AL., CANCER RES., (2005), vol. 65, pages 2882 - 2889 | - MILSTEIN; CUELLO, NATURE, (1983), vol. 305, pages 537 - 540 | - STAERZ ET AL., NATURE, (1985), vol. 314, pages 628 - 631 | - PEREZ ET AL., NATURE, (1985), vol. 316, pages 354 - 356 | - STAERZ; BEVAN, PROC NATL ACAD SCI U S A., (1986), vol. 83, pages 1453 - 1457 | - DEMONTE ET AL., PROC NATL ACAD SCI U S A., (1990), vol. 87, pages 2941 - 2945 | - HOLLIGER ET AL., PROC NATL ACAD SCI U S A., (1993), vol. 90, pages 6444 - 6448 | - ATWELL ET AL., MOL IMMUNOL., (1996), vol. 33, pages 1301 - 1302 | - HOLLIGER ET AL., NATURE BIOTECHNOL., (1997), vol. 15, pages 632 - 631 | - HELFRICH ET AL., INT. J CANCER, (1998), vol. 76, pages 232 - 239 | - KIPRIYANOV ET AL., INT J CANCER, (1998), vol. 77, pages 763 - 772 | - HOLLIGER ET AL., CANCER RES., (1999), vol. 59, pages 2909 - 2916 | - COCHLOVIUS ET AL., CANCER RES., (2000), vol. 60, pages 4336 - 4341 | - HOPPE ET AL., FEBS LETTERS, (1994), vol. 344, pages 191 - 195 | - NEWLON ET AL., EMBO J., (2001), vol. 20, pages 1651 - 1662 | - NEWLON ET AL., NATURE, (1999), vol. 3, pages 222 - 227 | - RUSTANDI ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 1951 - 1960 | - ROSE ET AL., NATURE STRUCT BIOL., (2000), vol. 7, pages 744 - 748 | - HODNELAND ET AL., PROC NATL ACD SCI U S A., (2002), vol. 99, pages 5048 - 5052 | - SILVA ET AL., FOOD TECHNOL BIOTECHNOL., (2004), vol. 42, pages 51 - 56 | - FANCY ET AL., CHEM BIOL., (1996), vol. 3, pages 551 - 559 | - BROWN ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 4397 - 4406 | - FANCY; KODADEK, PROC NATL ACAD SCI USA., (1999), vol. 96, pages 6020 - 6024 | - NEBLOCK ET AL., BIOCONJUGATE CHEM., (1991), vol. 3, pages 126 - 31 | - SHARKEY ET AL., INT. J. CANCER, (1992), vol. 51, page 266 | - MIZUKAMI ET AL., NATURE MED., (2005), vol. 11, pages 992 - 97 | - HATFIELD ET AL., CURR. CANCER DRUG TARGETS, (2005), vol. 5, pages 229 - 48 | - VALLBOHMER, J. CLIN. ONCOL., (2005), vol. 23, pages 3536 - 44 | - REN ET AL., ANN. SURG., (2005), vol. 242, pages 55 - 63 | - WALSH ET AL., J BIOL. CHEM., (1968), vol. 243, pages 3763 - 65 | - CORBIN ET AL., J. BIOL. CHEM., (1973), vol. 248, pages 1813 - 21 | - HAUSKEN ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 29016 - 22 | - SCOTT ET AL., J. BIOL. CHEM., (1990), vol. 265, pages 21561 - 66 | - LOHMANN ET AL., PROC. NATL. ACAD. SCI USA., (1984), vol. 81, pages 6723 - 27 | - WONG ET AL., NAT REV MOL CELL BIOL., (2004), vol. 12, pages 959 - 70 | - CARR ET AL., J. BIOL. CHEM., (1991), vol. 266, pages 14188 - 92 | - ALTO ET AL., PROC. NATL. ACAD. SCI USA., (2003), vol. 100, pages 4445 - 50 | - COLLEDGE ET AL., TRENDS CELL BIOL.., (1999), vol. 6, pages 216 - 21 | - BARBAS ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 119 | - WINTER ET AL., ANN. REV. IMMUNOL., (1994), vol. 12, page 433 | - GREEN ET AL., NATURE GENET., (1994), vol. 7, page 13 | - LONBERG ET AL., NATURE, (1994), vol. 368, page 856 | - TAYLOR ET AL., INT. IMMUN., (1994), vol. 6, page 579 | - GILLIES ET AL., J. HNMUNOL. METHODS, (1989), vol. 125, page 191 | - RYSER, PROC. NATL. ACAD. SCI. USA, (1978), vol. 75, pages 3867 - 3870 | - WROBEL; COLLINS, BIOCHIMICA ET BIOPHYSICA ACTA, (1995), vol. 1235, pages 296 - 304 | - LUNDBERG ET AL., J. PHARM. PHARMACOL., (1999), vol. 51, pages 1099 - 1105 | - LUNDBERG ET AL., INT. J. PHARM., (2000), vol. 205, pages 101 - 108 | - LUNDBERG, J. PHARM. SCI., (1994), vol. 83, pages 72 - 75 | - XU ET AL., MOLEC. CANCER THER., (2002), vol. 1, pages 337 - 346 | - TORCHILIN ET AL., PROC. NAT'L. ACAD. SCI., U.S.A., (2003), vol. 100, pages 6039 - 6044 | - WEST ET AL., APPLICATIONS OF NANOTECHNOLOGY TO BIOTECHNOLOGY, (2000), vol. 11, pages 215 - 217 | - BENDAS, BIODRUGS, (2001), vol. 15, pages 215 - 224 | - XU ET AL., MOL. CANCER THER, (2002), vol. 1, pages 337 - 346 | - TORCHILIN ET AL., PROC. NAT'L. ACAD. SCI. U.S.A, (2003), vol. 100, pages 6039 - 6044 | - BALLY ET AL., J. LIPOSOME RES., (1998), vol. 8, pages 299 - 335 | - LUNDBERG, INT. J. PHARM., (1994), vol. 109, pages 73 - 81 | - LUNDBERG, J. PHARM. PHARMACOL., (1997), vol. 49, pages 16 - 21 | - LUNDBERG, ANTI-CANCER DRUG DESIGN, (1998), vol. 13, pages 453 - 461 | - VAN DEN BERGH, CHEM. BRITAIN, (1986), vol. 22, page 430 | - MEW ET AL., J. IMMUNOL, (1983), vol. 130, page 1473 | - CANCER RES., (1985), vol. 45, page 4380 | - OSEROFFET, PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, page 8744 | - PHOTOCHEM. PHOTOBIOL., (1987), vol. 46, page 83 | - HASAN ET AL., PROG. CLIN. BIOL. RES., (1989), vol. 288, page 471 | - TATSUTA ET AL., LASERS SURG. MED., (1989), vol. 9, page 422 | - PELEGRIN ET AL., CANCER, (1991), vol. 67, page 2529 | - NAT BIOTECHNOL., (2005), vol. 23, pages 709 - 717 | - GENE THERAPY, (2006), vol. 13, pages 194 - 195 | - GOVINDAN ET AL., TECHNOLOGY IN CANCER RESEARCH & TREATMENT, (2005), vol. 4, pages 375 - 91 | - SHARKEY; GOLDENBERG, J. NUCL. MED., (2005), vol. 46, pages 115S - 127S | - GOLDENBERG ET AL., J CLIN ONCOL, (2006), vol. 24, pages 823 - 834 | - SHERWOOD ET AL., BIO/TECHNOLOGY, (1992), vol. 10, page 1446 | - SALTZMAN ET AL., BIOPHYS. J, (1989), vol. 55, page 163 | - PASTAN ET AL., CELL, (1986), vol. 47, page 641 | - GOLDENBERG, CA, A CANCER JOURNAL FOR CLINICIANS, (1994), vol. 44, page 43 | - GEORGAKIS ET AL., BR. J. HAEMATOL., (2005), vol. 130, pages 501 - 510 | - MORI ET AL., FEBS LETT., (2005), vol. 579, pages 5379 - 84 | - GOODWIN ET AL., J. NUCL. MED., (1988), vol. 29, page 226 | - HNATOWICH ET AL., J. NUCL. MED., (1987), vol. 28, page 1294 | - OEHR ET AL., J. NUCL. MED., (1988), vol. 29, page 728 | - KLIBANOV ET AL., J. NUCL. MED., (1988), vol. 29, page 1951 | - SINITSYN ET AL., J. NUCL. MED., (1989), vol. 30, page 66 | - KALOFONOS ET AL., J. NUCL. MED., (1990), vol. 31, page 1791 | - SCHECHTER ET AL., INT. J. CANCER, (1991), vol. 48, page 167 | - PAGANELLI ET AL., CANCER RES., (1991), vol. 51, page 5960 | - PAGANELLI ET AL., NUCL. MED. COMMUN., (1991), vol. 12, page 211 | - STICKNEY ET AL., CANCER RES., (1991), vol. 51, page 6650 | - YUAN ET AL., CANCER RES., (1991), vol. 51, page 3119 | - WAWRZYNCZAK; THORPE, Introduction to the Cellular and Molecular Biology of Cancer, OXFORD UNIVERSITY PRESS, (1986), pages 378 - 410 | - DILLMAN, R. O., CRC Critical Reviews in Oncology/Hematology, CRC PRESS, INC., (1984), vol. 1, page 357 | - VITETTA ET AL., SCIENCE, vol. 238, pages 1098 - 1104 | - BRADY ET AL., INT. J. RAD. ONCOL. BIOL. PHYS., (1987), vol. 13, pages 1535 - 1544 | - GOLDENBERG ET AL., "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radiotherapy", J. CLIN. ONCOL. | - SHARKEY; GOLDENBERG, J. NUCT..MED., (2005), vol. 46, pages 115S - 127S | - GOLDENBERG ET AL., "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy", J. CLIN. ONCOL. | - ZINSER ET AL., J. EXP MED., (2004), vol. 200, no. 3, pages 345 - 51 | - PALUMBO ET AL., "report that HMBG1 induces mesoangioblast migration and proliferation", J CELL BIOL, (2004), vol. 164, pages 441 - 449 | - YANG ET AL., PNAS USA, (2004), vol. 101, pages 296 - 301 | - KOKKOLA ET AL., ARTHRITIS RHEUM, (2003), vol. 48, pages 2052 - 8 | - CZURA ET AL., J INFECT DIS, (2003), vol. 187, no. 2, pages 391 - 6 | - TREUTIGER ET AL., JLNTERN MED, (2003), vol. 254, pages 375 - 85 | - HUBER-LANG, FASEB J, (2002), vol. 16, pages 1567 - 1574 | - RIEDEMANN, J CLIN INVEST, (2002), vol. 110, pages 101 - 108 | - HANGEN ET AL., J SURG RES, (1989), vol. 46, pages 195 - 199 | - STEVENS ET AL., J CLIN INVEST, (1986), vol. 77, pages 1812 - 1816 | - LO ET AL., BONE MARROW TRANSPLANT, (2002), vol. 30, no. 6, pages 375 - 80 | - BOUROS ET, PMC PULM MED, (2004), vol. 4, no. 1, page 6 | - CHEN ET AL., ARTERIOSCLER THROMB VASC BIOL, (2004), vol. 24, no. 4, pages 709 - 14 | - ULBRICHT ET AL., ARTHRITIS RHEUM, (2004), vol. 50, no. 8, pages 2717 - 8 | - LEIST ET AL., SCIENCE, (2004), vol. 305, no. 5681, pages 164 - 5 | - CUZZOLA ET AL., J IMMUNOL, (2000), vol. 164, pages 5871 - 5876 | - MEDVEDEV ET AL., JLMMUNOL, (1998), vol. 160, pages 4535 - 4542 | - WEYAND; GORONZY, N ENGL JMED, (2003), vol. 349, pages 160 - 169 | - HUNDER; VALENTE, Inflammatory Diseases of Blood Vessels, MARCEL DEKKER, (2002), pages 255 - 265 | - MA-KRUPA ET AL., J EXP MED, (2004), vol. 199, pages 173 - 183 | - GRAMMAR ET AL., J CLIN INVEST, (2003), vol. 112, pages 1506 - 1520 | - KELSOE, J CLIN INVEST, (2003), vol. 112, pages 1480 - 1482 | - KUWANA ET AL., BLOOD, (2004), vol. 103, pages 1229 - 1236 | - COHEN ET AL., ANN RHEUM DIS, (2004), vol. 63, pages 1062 - 8 | - COHEN, RHEUM DIS CLIN NORTH AM, (2004), vol. 30, pages 365 - 80 | - TAYLOR, CURR OPIN PHARMACOL, (2003), vol. 3, pages 323 - 328 | - SMITH; SCOTT, SCIENCE, (1985), vol. 228, pages 1315 - 1317 | - SMITH; SCOTT, METH. ENZYMOL., (1993), vol. 21, pages 228 - 257 | - ARAP ET AL., SCIENCE, (1998), vol. 279, pages 377 - 380 | - PASQUALINI; RUOSLAHTI, NATURE, (1996), vol. 380, pages 364 - 366 | - PASQUALINI, THE QUART. J. NUCL. MED., (1999), vol. 43, pages 159 - 162 | - SILVERMAN ET AL., NAT. BIOTECHNOL., (2005), vol. 23, pages 1493 - 94 | - SILVERMAN ET AL., NAT. BIOTECHNOL., (2006), vol. 24, page 220 | - PRICKETT ET AL., BIOTECHNIQUES, (1989), vol. 7, pages 580 - 589 | - CASTRUCCI ET AL., J VIROL, (1992), vol. 66, pages 4647 - 4653 | - TAM ET AL., J. AM. CHEM. SOC., (1983), vol. 105, page 6442 | - MERRIFIELD, SCIENCE, (1986), vol. 232, pages 341 - 347 | - BARANY; MERRIFIELD, The Peptides, ACADEMIC PRESS, (1979), pages 1 - 284 | - BLONDELLE ET AL., BIOPHYS. J., (1995), vol. 69, pages 604 - 11 | - ECKER; CROOKE, BIOTECHNOLOGY, (1995), vol. 13, pages 351 - 69 | - GOODMAN; RO, BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY, JOHN WILEY & SONS, (1995), vol. I | - GOODMAN; SHAO, PURE & APPL. CHEM., (1996), vol. 68, pages 1303 - 08 | - HRUBY, LIFE SCI, (1982), vol. 31, pages 189 - 99 | - HOLLADAY ET AL., TETRAHEDRON LETT., (1983), vol. 24, pages 4401 - 04 | - JENNINGS-WHITE ET AL., TETRAHEDRON LETT., (1982), vol. 23, page 2533 | - ALMQUIEST ET AL., J. MED. CHEM., (1980), vol. 23, pages 1392 - 98 | - HUDSON ET AL., INT. J PEPT. RES., (1979), vol. 14, pages 177 - 185 | - SPATOLA ET AL., LIFE SCI, (1986), vol. 38, pages 1243 - 49 | - ZIV ET AL., J. BONE MINER. RES., (1994), vol. 18, no. 2, pages 792 - 94 | - SOLTERO; EKWURIBE, PHARM. TECHNOL., (2001), vol. 6, page 110 | - LOW ET AL., HUM. REPROD., (2005), vol. 20, pages 1805 - 13 | - DUMONT ET AL., J. AEROSOL. MED., (2005), vol. 18, pages 294 - 303 | - NISONOFF ET AL., ARCH. BIOCHEM. BIOPHYS., (1960), vol. 89, page 230 | - PORTER, BIOCHEM. J., (1959), vol. 73, page 119 | - EDELMAN ET AL., METHODS IN ENZYMOLOGY, ACADEMIC PRESS, (1967), page 422 | - INBAR ET AL., PROC. NAT'1. ACAD. SCI. USA, (1972), vol. 69, page 2659 | - SANDHU, CRIT. REV. BIOTECH., (1992), vol. 12, page 437 | - WHITLOW ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 97 | - BIRD ET AL., SCIENCE, (1988), vol. 242, page 423 | - PACK ET AL., BIO/TECHNOLOGY, (1993), vol. 11, page 1271 | - LARRICK ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 106 | - RITTER ET AL., MONOCLONAL ANTIBODIES: PRODUCTION, ENGINEERING AND CLINICAL APPLICATION, CAMBRIDGE UNIVERSITY PRESS, (1995), pages 166 - 179 | - BIRCH ET AL.,, MONOCLONAL ANTIBODIES: PRINCIPLES AND APPLICATIONS, WILEY-LISS, INC., (1995), pages 137 - 185 | - LEUNG ET AL., HYBRIDOMA, (1994), vol. 13, page 469 | - JONES ET AL., NATURE, (1986), vol. 321, page 522 | - RIECHMANN ET AL., NATURE, (1988), vol. 332, page 323 | - VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, page 1534 | - CARTER ET AL., PROC. NAT'L ACAD. SCI. USA, (1992), vol. 89, page 4285 | - TEMPEST ET AL., BIOTECHNOLOGY, (1991), vol. 9, page 266 | - SINGER ET AL., J. MUMMOL., (1993), vol. 150, page 2844 | - LOSMAN ET AL., INT. J. CANCER, (1990), vol. 46, page 310 | - MANCINI ET AL., NEW MICROBIOL., (2004), vol. 27, pages 315 - 28 | - CONRAD; SCHELLER, COMB. CHEM. HIGH THROUGHPUT SCREEN., (2005), vol. 8, pages 117 - 26 | - BREKKE; LOSET, CURR. OPIN. PHAMACOL., (2003), vol. 3, pages 544 - 50 | - DANTAS-BARBOSA ET AL., GENET. MOL. RES., (2005), vol. 4, pages 126 - 40 | - MARKS ET AL., J. MOL. BIOL., (1991), vol. 222, pages 581 - 97 | - ANDRIS-WIDHOPF ET AL., Phage Display Laboratory Manual, COLD SPRING HARBOR LABORATORY PRESS, (2000), pages 9.1 - 9.22 | - GREEN ET AL., J. IMMUNOL. METHODS, (1999), vol. 231, pages 11 - 23 | - "Cell Marking Techniques and Their Application", PONDER, MAMMALIAN DEVELOPMENT: A PRACTICAL APPROACH, IRL PRESS, (1987), vol. 113-38, pages 5.8.1 - 5.8.8 | - KENNEDY ET AL., CLIN. CHIM. ACTA, (1976), vol. 70, page 1 | - SCHURS ET AL., CLIN. CHIM. ACTA, (1977), vol. 81, page 1 | - SHIH ET AL., INT'L J. CANCER, (1990), vol. 46, page 1101 | - "Medical Applications of Radioisotopes", CHASE ET AL., REMINGTON'S PHARMACEUTICAL SCIENCES, MACK PUBLISHING CO., (1990), pages 624 - 652 | - "Clinical Use of Monoclonal Antibodies", BROWN ET AL., BIOTECHNOLOGY AND PHARMACY, CHAPMAN & HALL, (1993), pages 227 - 49 | - GOLDENBERG ET AL., "Antibody Pre-targeting Advances Cancer Radioimmunodetection and Radioimmunotherapy", J CLIN ONCOL, (2006), vol. 24, pages 823 - 834 | - LEE; MEISEL, J. PHYS. CHEM., (1982), vol. 86, pages 3391 - 3395 | - GILLIES ET AL., J IMMUNOL METHODS, (1989), vol. 125, pages 191 - 202 | - LOSMAN ET AL., CANCER (PHILA, (1997), vol. 80, pages 2660 - 6 | - ALTO ET AL., PROC. NATL. ACAD. SCI., U.S.A, (2003), vol. 100, pages 4445 - 50 | - LE DOUSSAL ET AL., J NUCL MED, (1989), vol. 30, pages 1358 - 66 | - ROSSI ET AL., CLIN CANCER RES., (2005), vol. 11, no. 19, pages 7122S - 7129S | - DOHERTY ET AL., BIOCONJUGATE CHEM., (2005), vol. 16, pages 1291 - 1298 | - CWIRTA ET AL., SCIENCE, (1997), vol. 276, pages 1696 - 1699 | - SHIH ET AL., "conjugation of anthracyclin to amino-dextran", CANCER RES., (1991), vol. 51, pages 4192 - 4198 | - TACKEN ET AL., J. IMMUNOL., (2004), vol. 172, pages 4934 - 4940 | - BROKX ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 2327 - 2332 | - ROSSI ET AL., PROC NATL ACAD SCI USA., (2006), vol. 103, no. 18, pages 6841 - 6 | US20050296432 | US20030350096 | US20010921290 | US20010342104 | US20030361026 | US19990337756 | US20010823746 | US20020116116 | US19990382186 | US20020150654 | US20020114315 | US20020386411 | US20020345641 | US20010328835 | US20020426379 | US20010342103 | US20040634076 |